Point72 Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-67,070
| Closed | -$149K | – | 1370 |
|
2024
Q2 | $149K | Buy |
67,070
+51,000
| +317% | +$113K | ﹤0.01% | 1038 |
|
2024
Q1 | $43.1K | Buy |
16,070
+11,270
| +235% | +$30.2K | ﹤0.01% | 1352 |
|
2023
Q4 | $14.4K | Sell |
4,800
-3,093,052
| -100% | -$9.25M | ﹤0.01% | 1314 |
|
2023
Q3 | $3.04M | Sell |
3,097,852
-1,877,148
| -38% | -$1.84M | 0.01% | 783 |
|
2023
Q2 | $6.92M | Buy |
4,975,000
+1,375,000
| +38% | +$1.91M | 0.02% | 590 |
|
2023
Q1 | $5.72M | Buy |
3,600,000
+1,323,000
| +58% | +$2.1M | 0.02% | 621 |
|
2022
Q4 | $14.2M | Sell |
2,277,000
-511,300
| -18% | -$3.19M | 0.05% | 412 |
|
2022
Q3 | $18.7M | Buy |
2,788,300
+1,725,204
| +162% | +$11.6M | 0.07% | 325 |
|
2022
Q2 | $6.76M | Buy |
+1,063,096
| New | +$6.76M | 0.03% | 546 |
|
2021
Q2 | – | Sell |
-648,200
| Closed | -$18.2M | – | 969 |
|
2021
Q1 | $18.2M | Buy |
+648,200
| New | +$18.2M | 0.08% | 273 |
|
2020
Q1 | – | Sell |
-4,800
| Closed | -$286K | – | 828 |
|
2019
Q4 | $286K | Sell |
4,800
-414,590
| -99% | -$24.7M | ﹤0.01% | 781 |
|
2019
Q3 | $15.4M | Buy |
419,390
+352,617
| +528% | +$12.9M | 0.09% | 252 |
|
2019
Q2 | $3.11M | Sell |
66,773
-150,327
| -69% | -$6.99M | 0.02% | 510 |
|
2019
Q1 | $8.72M | Buy |
+217,100
| New | +$8.72M | 0.04% | 379 |
|
2018
Q4 | – | Sell |
-507,300
| Closed | -$22.5M | – | 913 |
|
2018
Q3 | $22.5M | Buy |
507,300
+143,200
| +39% | +$6.35M | 0.09% | 207 |
|
2018
Q2 | $14.3M | Buy |
+364,100
| New | +$14.3M | 0.06% | 286 |
|
2015
Q4 | – | Sell |
-77,000
| Closed | -$1.82M | – | 668 |
|
2015
Q3 | $1.82M | Buy |
77,000
+38,200
| +98% | +$901K | 0.01% | 525 |
|
2015
Q2 | $3.17M | Buy |
+38,800
| New | +$3.17M | 0.02% | 479 |
|
2015
Q1 | – | Sell |
-10,700
| Closed | -$433K | – | 664 |
|
2014
Q4 | $433K | Buy |
+10,700
| New | +$433K | ﹤0.01% | 576 |
|